Year: 2025

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 96,100 shares of its common stock to sixteen new non-executive employees and 100,000 to one new executive employee under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4). The 2021 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Crinetics, or following a bona fide period of non-employment,...

BETHESDA, Md., Jan. 10, 2025 (GLOBE NEWSWIRE) — Eagle Bancorp, Inc. (NASDAQ: EGBN) (“Eagle”) today announced that (i) the expiration date has been extended until 5:00 p.m. (Eastern Time) on January 14, 2025 (the “Extended Expiration Date”) with respect to its previously announced offer to exchange (the “Exchange Offer”) its outstanding unregistered 10.00% Senior Notes due 2029 (the “Original Notes”) for a like principal amount of notes of the same series that have been registered under the Securities Act of 1933, as amended (the “Exchange Notes”) and (ii) the result, as of 5:00 p.m. (Eastern Time) on January 10, 2025 (the “Original Expiration Date”), of such offer to exchange. The Exchange Offer will now expire at 5:00 p.m., Eastern time, on January 14, 2025, unless extended or earlier terminated by Eagle (such date and time, as...

BEDMINSTER, N.J. , Jan. 10, 2025 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that on January 6, 2025, it received a NYSE American LLC notice indicating that the Company has fallen below certain NYSE American continued listing standards because it failed to hold its annual meeting of stockholders for the fiscal year ending on December 31, 2024, as set forth in Section 704 of the NYSE American Company Guide. The Company intends to hold its annual meeting no later than December 31, 2025 in order to regain compliance under the NYSE American Company Guide. About Matinas BioPharma Matinas BioPharma is a biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology. For more information, please visit www.matinasbiopharma.com. Forward-looking...

NEWBURYPORT, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) — UFP Technologies, Inc. (Nasdaq: UFPT) an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming CJS Securities 25th Annual “New Ideas for the New Year” Conference to be held virtually on January 14, 2025. UFP’s presentation is scheduled to begin at 8:45 AM ET on Tuesday, January 14, 2025. About UFP Technologies, Inc.UFP Technologies is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP is an important link in the medical device supply chain and a valued outsourcing...

HOUSTON, Jan. 10, 2025 (GLOBE NEWSWIRE) — Freight Technologies, Inc. (Nasdaq: FRGT) (“Fr8Tech” or “Freight Technologies” or the “Company”), a logistics management innovation company, offering a diverse portfolio of technology-driven solutions that address distinct challenges within the supply chain ecosystem, today announced that it has changed its independent registered public accounting and auditing firm from Marcum LLP (“Marcum” or “Former Auditor”) to TAAD LLP (“TAAD” or Successor Auditor”), effective immediately. The Successor Auditor’s engagement became effective January 6, 2025, and until the next Annual General Meeting of the Company, while, at the request of the Company, the Former Auditor resigned effective January 7, 2025. The decision to change the independent registered public accounting firm was recommended...

HAUPPAUGE, N.Y., Jan. 10, 2025 (GLOBE NEWSWIRE) — Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company”) today announced that the Company expects to release its earnings for the quarter ended December 31, 2024 before the open of the U.S. equity markets on Thursday, January 23, 2025. The Company will conduct a conference call at 8:30 a.m. (ET) on Thursday, January 23, 2025, during which President and Chief Executive Officer (“CEO”), Stuart Lubow, will discuss the Company’s fourth quarter financial performance. There will be a question-and-answer period after the CEO remarks. Participants may access the conference call via webcast using this link: Webcast Link Here. To participate via telephone, please register in advance using this Registration Link. Upon registration, all telephone participants will receive...

HONG KONG, Jan. 10, 2025 (GLOBE NEWSWIRE) — Raytech Holding Limited (the “Company” or “RAY”), a Hong Kong-headquartered company specializing in design, sourcing and wholesale of personal care electrical appliances for international brand owners, today announced its financial results for the six months ended September 30, 2024. CHING Tim Hoi, CEO and Chairman of the Company, commented, “The Company achieved a notable 31.0% increase in revenue for the six months ended September 30, 2024, reaching HKD 43.2 million (US$ 5.6 million), up from HKD 33.0 million in the prior year. This growth was driven primarily by strong sales in our trimmer series within the personal care products segment, reflecting our success in attracting new customers.” “However, operating expenses rose sharply, with merchandise costs increasing by 40.3% to HKD...

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the closing of its previously announced public offering of 5,000,000 shares of common stock at $0.85 per share for gross proceeds of approximately $4.25 million. Ladenburg Thalmann & Co. Inc. acted as the exclusive placement agent for this offering. The securities described above public offering were offered pursuant to registration statements on Form S-3 (File No. 333-282456), which were declared effective by the United States Securities and Exchange Commission (“SEC”) on October 10, 2024. The offering was made solely by means of a prospectus. A final prospectus relating to the offering was...

Company management will participate in 1-on-1 meetings with institutional, private equity, and venture capital investors NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) — REE Automotive Ltd. (Nasdaq: REE), an automotive technology company and provider of full by-wire electric trucks and platforms, will participate in the 27th Annual Needham Growth Conference in New York City on January 14, 2025. Company leadership including the CEO and co-founder Daniel Barel, CFO Hai Aviv and Chief Strategy Officer Dana Rubenstein will participate in 1-on-1 meetings to discuss the company’s software-defined vehicle (SDV) technology, market opportunities and goals for the future. Conference participants may schedule a meeting with REE by contacting Dana Rubenstein at danar@ree.auto. To learn more about REE Automotive’s patented technology and unique value...